Medicure Inc (OP:MCUJF)

Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial

September 28, 2026

Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress

Performance

52-Week Range

2.020

0.6752W Low 2.0252W High

1 Week

1.851W Low 2.021W High

Medicure Inc (MCUJF) traded between $0.67 and $2.02 over the past 52 weeks and last traded at $2.02. Over the past week it ranged between $1.85 and $2.02.

Past 12 Months

+6.3%

+9.2%

+136.1%

+118.3%

+128.1%

+182.0%

1W +$0.12

1M +$0.17

3M +$1.16

6M +$1.09

YTD +$1.13

1Y +$1.30

MCUJF was +182.0% over the past year, +118.3% over six months, +128.1% year to date, +6.3% in the last week.

12 Months vs Market

MCUJF

+182.0%

DIA

+10.2%

SPY

+15.5%

QQQ

+25.0%

IWM

+16.7%

Over the past 12 months MCUJF returned +182.0% versus DIA (Dow) +10.2%, SPY (S&P 500) +15.5%, QQQ (Nasdaq 100) +25.0% and IWM (Russell 2000) +16.7%.

Volume & Liquidity 0.00× 3-mo avg

Today 8 3-mo avg 10.9K

8.2K

11.6K

10.9K

9.0K

YTD

7.8K

6.8K

MCUJF most recently traded 8 shares against a 3-month average daily volume of 10.9K.

More News

September 08, 2026

Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call

August 14, 2026

Medicure Announces CFO Change

July 03, 2026

Medicure Announces AGM Results and Appointment of New Director

May 21, 2026

Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call

May 21, 2026

Medicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference Call

April 23, 2026

Medicure Announces Resignation of President and Chief Operating Officer

April 17, 2026

Medicure Reports Financial Results for Quarter Ended September 30, 2025

November 19, 2025

Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025

November 13, 2025

Medicure Reports Financial Results for Quarter Ended June 30, 2025

August 20, 2025

Medicure to Present Financial Results on August 21, 2025 Call at 8:30 am ET for Quarter Ended June 30, 2025

August 18, 2025

Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy

June 17, 2025

Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results

May 21, 2025

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024

April 25, 2025

Medicure to Present Financial Results on April 29, 2025 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2024

April 22, 2025

Medicure Announces Further Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of West Olympia Pharmacy

April 11, 2025

Medicure Announces Closing of Purchase Agreement for the Acquisition of Gateway Medical Pharmacy

March 11, 2025

Medicure Announces Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of Gateway Medical Pharmacy

February 18, 2025

Medicure Reports Financial Results For Quarter Ended September 30, 2024

November 25, 2024

Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member

November 18, 2024

Medicure Announces Positive Settlement of Product Development and Supply Contracts

October 24, 2024

Medicure Reports Financial Results for Quarter Ended June 30, 2024

August 14, 2024

Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property

June 24, 2024